SOLUM COSMETIC acquires 35.3% of I-CURE for 21.2B KRW
솔루엠
248070
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=627
Risk-adjusted indicator based on 627 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Acquisition Amount: 21,200,000,668 KRW
- • Acquired Shares: 20,502,902 Shares
- • Post-acquisition Ownership: 35.3%
- • Acquisition Target's 2025 Revenue: 83,385M KRW
- • Acquisition Target's 2025 Net Income: -34,515M KRW
AI Analysis Summary
SOLUM CO., LTD.'s subsidiary, SOLUM COSMETIC CORP., decided to acquire 20,502,902 shares of I-CURE for 21.2 billion KRW, representing a 35.3% stake. The acquisition aims to strengthen competitiveness and create synergy with existing portfolios in the cosmetics manufacturing sector. I-CURE's 2025 revenue was 83.385 billion KRW, with a net loss of 34.515 billion KRW. The acquisition amount represents 1.7% of SOLUM's total assets. The transaction is subject to government approvals and other conditions, with an expected acquisition date of August 6, 2026.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.